摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 2-(chlorosulfonyl)thiophene-3-carboxylate | 59338-05-5

中文名称
——
中文别名
——
英文名称
methyl 2-(chlorosulfonyl)thiophene-3-carboxylate
英文别名
2-chlorosulfonylthiophene-3-carboxylic acid methyl ester;methyl 2-chlorosulfonylthiophene-3-carboxylate
methyl 2-(chlorosulfonyl)thiophene-3-carboxylate化学式
CAS
59338-05-5
化学式
C6H5ClO4S2
mdl
MFCD08695553
分子量
240.688
InChiKey
QVFDAOAJMMCUGI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    13
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.166
  • 拓扑面积:
    97.1
  • 氢给体数:
    0
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    methyl 2-(chlorosulfonyl)thiophene-3-carboxylate4-{[6-cyano-1-(3-methyl-3H-imidazol-4-ylmethyl)-1,2,3,4-tetrahydroquinolin-3-ylamino]methyl}-piperidine-1-carboxylic acid methyl esterN,N-二异丙基乙胺 作用下, 以 二氯甲烷 为溶剂, 反应 1.0h, 生成 methyl 4-[[[6-cyano-1-[(3-methylimidazol-4-yl)methyl]-3,4-dihydro-2H-quinolin-3-yl]-(3-methoxycarbonylthiophen-2-yl)sulfonylamino]methyl]piperidine-1-carboxylate
    参考文献:
    名称:
    Second Generation Tetrahydroquinoline-Based Protein Farnesyltransferase Inhibitors as Antimalarials
    摘要:
    Substituted tetrahydroquinolines (THQs) have been previously identified as inhibitors of mammalian protein farnesyltransferase (PFT). Previously we showed that blocking PFT in the malaria parasite led to cell death and that THQ-based inhibitors are the most potent among several structural classes of PFT inhibitors (PFTIs). We have prepared 266 THQ-based PFTIs and discovered several compounds that inhibit the malarial enzyme in the sub- to low-nanomolar range and that block the growth of the parasite (P. falciparum) in the lownanomolar ran-e. This body of structure- activity data can be rationalized in most cases by consideration of the X-ray structure of one of the THQs bound to mammalian PFT together with a homology structural model of the malarial enzyme. The results of this study provide the basis for selection of antimalarial PFTIs for further evaluation in preclinical drug discovery assays.
    DOI:
    10.1021/jm0703340
  • 作为产物:
    描述:
    2-chlorosulfonylthiophene-3-carboxylic acid chloride 以 甲醇氯仿 为溶剂, 生成 methyl 2-(chlorosulfonyl)thiophene-3-carboxylate
    参考文献:
    名称:
    Thiazine derivatives
    摘要:
    具有以下公式的抗炎、镇痛、抗风湿和抗血栓的噻吩噻唑衍生物:其中A与两个碳原子一起形成基团,虚线表示上述第一个和最后一个噻吩结构中存在的双键,R.sup.1是低碳基,R.sup.2是含有1至4个杂原子的芳香杂环的基团,可选择地被一个或两个低碳基取代,或是一个苯基基团,可选择地被卤素、羟基、低碳基、三氟甲基或低碳氧基取代,R.sup.3是卤素,R.sup.3'是氢或卤素,以及其药用可接受盐。
    公开号:
    US04180662A1
点击查看最新优质反应信息

文献信息

  • Double C–N bond cleavages of <i>N</i>-alkyl 4-oxopiperidinium salts: access to unsymmetrical tertiary sulfonamides
    作者:Ying Fu、Ming-Peng Li、Chun-Zhao Shi、Fang-Rong Li、Zhengyin Du、Congde Huo
    DOI:10.1039/c9ob02107h
    日期:——
    paper, regiospecific, double intraannular C–N bond cleavages of N-alkyl 4-oxopiperidinium salts are presented. The reaction sequence involves a charge-transfer complex, in situ formed between sulfonyl chloride and N-methylmorpholine, which induces S–Cl bond homolysis of sulfonyl chloride, yielding a reactive sulfonyl radical that further induces the double C–N bond cleavages of N-alkyl 4-oxopiperidinium
    在本文中,提出了N-烷基4-氧代哌啶鎓盐的区域特异性双环内C–N键裂解。反应顺序包括一个电荷转移络合物,原位磺酰氯和之间形成Ñ甲基吗啉,磺酰氯,其诱导S-Cl键均裂,产生反应性基团磺酰进一步诱导的双C-N键断裂ñ -烷基4-氧代哌啶鎓盐。如此产生的仲胺被磺酰氯捕获,得到所需的磺酰胺产物。该协议的关键特征是,在无属和无氧化剂的条件下,一步切割了4-氧杂环哌啶环的两个环内C–N键。
  • Identification and Validation of PKR as a Direct Target for the Novel Sulfonamide-Substituted Tetrahydroquinoline Nonselective Inhibitor of the NLRP3 Inflammasome
    作者:Fan Yang、Zhen Dai、Ming-yue Xue、Xiao-yi Chen、Juan Liu、Li Wang、Li-li Xu、Bin Di
    DOI:10.1021/acs.jmedchem.4c00343
    日期:2024.6.27
    S-9, photoaffinity probe P-2, which contained a photoaffinity label and a functional handle, was developed for target identification by chemical proteomics. We identified PKR as a novel target of S-9 in addition to NLRP3 by target fishing. Furthermore, S-9 exhibited a significant anti-neuroinflammatory effect in vivo. In summary, our findings show that S-9 is a promising lead compound targeting both
    NLRP3 炎症小体是先天免疫系统的重要组成部分。 NLRP3 炎性体的持续异常激活与许多人类疾病有关。在此,磺酰胺取代的四氢喹啉生物S-9被认为是最有前途的NLRP3抑制剂,且没有明显的细胞毒性。在体外, S-9抑制 NLRP3 炎性体的启动和激活阶段。顺便说一句,我们还观察到S-9对NLRC4和AIM2炎症小体有抑制作用。为了阐明S-9的多种抗炎活性,开发了包含光亲和标记和功能手柄的光亲和探针P-2 ,用于化学蛋白质组学的靶点识别。我们通过靶向捕捞确定了 PKR 是除 NLRP3 之外的S-9的新靶点。此外, S-9在体内表现出显着的抗神经炎症作用。总之,我们的研究结果表明, S-9是一种有前途的针对 PKR 和 NLRP3 的先导化合物,可以作为治疗炎症小体相关疾病的分子工具。
  • US4180662A
    申请人:——
    公开号:US4180662A
    公开(公告)日:1979-12-25
  • US4187303A
    申请人:——
    公开号:US4187303A
    公开(公告)日:1980-02-05
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)